Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

RZLT

Rezolute (RZLT)

Rezolute Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:RZLT
일자시간출처헤드라인심볼기업
2024/05/1805:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
2024/05/1605:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
2024/05/1605:05GlobeNewswire Inc.Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
2024/04/2321:00GlobeNewswire Inc.Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual MeetingNASDAQ:RZLTRezolute Inc
2024/03/1206:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
2024/03/1123:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
2024/03/0621:30GlobeNewswire Inc.Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)NASDAQ:RZLTRezolute Inc
2024/02/2722:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
2024/02/2307:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
2024/02/2201:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
2024/02/1407:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RZLTRezolute Inc
2024/02/1406:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
2024/02/1406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
2024/02/1406:05GlobeNewswire Inc.Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
2024/01/3007:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
2024/01/2602:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
2024/01/2602:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
2024/01/2602:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
2024/01/2602:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
2024/01/2422:00GlobeNewswire Inc.Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial OfficerNASDAQ:RZLTRezolute Inc
2024/01/2322:00GlobeNewswire Inc.Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
2023/12/1506:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
2023/12/1422:00GlobeNewswire Inc.Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
2023/12/1322:00GlobeNewswire Inc.Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)NASDAQ:RZLTRezolute Inc
2023/11/3014:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RZLTRezolute Inc
2023/11/2307:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:RZLTRezolute Inc
2023/11/2306:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
2023/11/1722:00GlobeNewswire Inc.Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology DayNASDAQ:RZLTRezolute Inc
2023/11/1523:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RZLTRezolute Inc
2023/11/1406:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
 검색 관련기사 보기:NASDAQ:RZLT